OPKO HEALTH, INC.

CIK 0000944809

1 SPAC with a current declared position, filed between Nov 20, 2024 and Nov 20, 2024. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.

This filer has not filed a Schedule 13 on any SPAC since Nov 20, 2024. Read the page below as a record of what was declared, not as a register of what is held.

Filed under 3 earlier names

Opko Health, Inc. · eXegenics Inc · EXEGENICS INCEDGAR’s own former-name record for CIK 0000944809. The page did not move when the filer renamed, because the identity is the CIK and the URL is a label it owns.

SPACs declared

every position whose latest statement stands — the record

Re-affirmed in 12 months

filed inside 365 days — what a reader means by "owns"

Still live

positions in SPACs still searching or in an announced deal

Median stake

5.0%

no percentage stated on the cover pages

1 activist (13D)9 superseded statements on file

Positions

one row per SPAC — every figure read from the accession in the Source column

1 of 1 shown · 1 position has not been amended in over a year

	SPAC			Voting	Dispositive			Source
CMLF	CM Life Sciences, Inc.	5.0%	1,370,841	1,370,841 / —	1,370,841 / —	Closed (deSPAC)	Nov 20, 2024Stale	SC 13D/A · may seek to influence control0001437749-24-035895 9 earlier statements

9 superseded statements

An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.

CMLF CM Life Sciences, Inc.6.4% · SC 13D/A Nov 8, 2024replaced Nov 20, 2024 by 0001437749-24-035895
CMLF CM Life Sciences, Inc.8.1% · SC 13D/A Sep 18, 2024replaced Nov 8, 2024 by 0001437749-24-034241
CMLF CM Life Sciences, Inc.9.3% · SC 13D/A Aug 23, 2024replaced Sep 18, 2024 by 0001437749-24-029481
CMLF CM Life Sciences, Inc.10.4% · SC 13D/A Aug 12, 2024replaced Aug 23, 2024 by 0001437749-24-027693
CMLF CM Life Sciences, Inc.11.9% · SC 13D/A Jul 26, 2024replaced Aug 12, 2024 by 0001437749-24-026120
CMLF CM Life Sciences, Inc.13.3% · SC 13D/A Jul 5, 2024replaced Jul 26, 2024 by 0001437749-24-023645
CMLF CM Life Sciences, Inc.14.3% · SC 13D/A Apr 20, 2023replaced Jul 5, 2024 by 0001437749-24-022249
CMLF CM Life Sciences, Inc.11.6% · SC 13D/A Feb 3, 2023replaced Apr 20, 2023 by 0000944809-23-000018
CMLF CM Life Sciences, Inc.21.2% · SC 13D May 9, 2022replaced Feb 3, 2023 by 0000944809-23-000004

Appears alongside

other filers with a current declared position in the same SPACs

Co-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.

Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.